Back to Journals » Therapeutics and Clinical Risk Management » Volume 11

Xerostomia induced by radiotherapy

Authors Alimi D

Received 6 May 2015

Accepted for publication 19 May 2015

Published 5 August 2015 Volume 2015:11 Pages 1149—1152

DOI https://doi.org/10.2147/TCRM.S88021

Checked for plagiarism Yes

Editor who approved publication: Professor Garry Walsh


David Alimi

Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA

We read with great interest the excellent review on xerostomia induced by radiotherapy, by Pinna et al.1 The authors should be congratulated for a very detailed review of the physiopathology, clinical symptoms, and therapeutic management of an extremely difficult condition. Although we agree that the use of anticholinergic medication represents treatment, it requires the patient to have residual salivary gland function. Unfortunately, it is well established that in most cases radiotherapy destroys most of the salivary gland and associated salivary secretions.   
 
 

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]